Sector: Life Sciences

Latest content

Sanofi farms out more IP as part of “play to win” strategy

The French company is one of several big pharmas to have offloaded deprioritised drugs in recent months

29 July 2022

Teva’s skinny label SCOTUS petition is a must-watch for generics

The move is the company’s final resort as it seeks to overturn a $235 million damages decision that has major IP implications for the entire pharmaceutical industry

28 July 2022

USPTO proposals in danger of damaging US innovation system, warns Novartis IP policy chief

Corey Salsberg fears current batch of patent reform suggestions are being driven by a false narrative

25 July 2022

Illumina pays $325 million for patent litigation ceasefire with Chinese rival

The limited deal only covers the US, which means the company’s disputes with BGI over gene sequencing technology look set to continue elsewhere

21 July 2022

Royalty Pharma spends $1.3 billion in latest drug revenue rights purchase

Royalty transactions are an increasingly attractive means of cashing in on life sciences innovation, and the returns can be significant

15 July 2022

Covid-19 patent wars spread to Europe as CureVac sues BioNTech

German mRNA innovators poised for fight over vaccine revenues in the Dusseldorf Regional Court

08 July 2022

The EU SPC manufacturing waiver transitional period comes to an end

Life sciences companies in Europe are now operating under a regime in which many more patent extension rights are affected by exemptions

05 July 2022

Pfizer to commercialise its IP with the help of trailblazing Roivant approach

The partnership is aimed at helping the pharma giant to moentise deprioritised IP in the autoimmune space

04 July 2022

Covid-19 has exposed the limits of compulsory licensing

The pandemic has brought the difficulties of bypassing life sciences IP into plain view

02 July 2022

Big week for US patent eligibility leaves resolution of “morass of uncertainty” still unclear

Despite a USPTO report, the Supreme Court’s decision not to hear the American Axle case leaves many doubtful that there will be any clarity in the immediate future

01 July 2022

Unlock unlimited access to all IAM content